Study identifies possible connection to autism development
In the last few years, several studies have highlighted the link between our gut microbiota and our general health.
This connection affects everything from our mental health to how we handle stress and our risk for autoimmune diseases like rheumatoid arthritis and type 1 diabetes, showing just how important our gut flora is.
A new study in The Journal of Immunology provides new information about the connection between the microbiome and autism.
According to the World Health Organization, autism is described as a variety of conditions that relate to brain development, impacting social interaction and communication.
Additionally, the WHO mentions that individuals with autism “often experience other conditions, such as epilepsy, depression, anxiety, and attention deficit hyperactivity disorder, along with challenging behaviors like trouble sleeping and self-harm.” The intellectual abilities of these individuals vary from person to person.
Research indicates that the microbiota from our mothers has a bigger impact on whether we develop autism than our own microbiota.
John Lukens, the lead researcher and PhD student at the University of Virginia School of Medicine, stated, “The microbiome can influence the developing brain in many ways.”
He also added, “The microbiome plays a crucial role in how the immune system of the offspring will react to infections, injuries, or stress.”
What holds the clue between microbiome and autism might be a molecule produced by the immune system called interleukin-17a, or IL-17a.
Research has shown that this cytokine is involved in diseases like psoriasis, multiple sclerosis, and rheumatoid arthritis, and it is important for protecting the body from fungal infections. But it also seems to affect brain development while in the womb.
Scientists conducted their research on mice that had different gut bacteria. One group had bacteria that caused a stronger inflammatory response due to IL-17a, while the control group did not have this.
When they artificially reduced IL-17a in the young mice, both groups acted normally at first. However, later on, when the scientists stopped interfering and the mice grew up on their own, the first group started showing signs of autism, like repeating behaviors.
After that, researchers took the poop from the first group of mice and did a fecal transplant to the second group to transfer the pro-inflammatory gut bacteria. As expected, the mice in the second group also began to show autism-like behaviors.
Although researchers have only tested this study on mice, it lays the groundwork for more research that could show how much a mother’s gut health affects the development of neurodevelopmental disorders.
“When it comes to applying our findings to humans, I believe the next major step would be to find characteristics of the microbiome in pregnant women that relate to autism risk,” Lukens said. “The key thing is to discover what methods can safely and effectively change the microbiome in mothers.”
While blocking IL-17a might help prevent autism, Lukens mentioned that it carries some risks. “If you consider pregnancy, the body is essentially accepting foreign tissue, which is the baby,” he explained. “Therefore, keeping the embryo healthy requires a careful balance of immune regulation, so people usually avoid altering the immune system during pregnancy.”
He pointed out that there are many other molecules to investigate since IL-17a is just a small part of a much larger picture.
Please SHARE this article with your family and friends on Facebook.




